OSCR
Oscar Health, Inc.
OSCR has the edge over SIGA overall, supported by stronger fundamentals and lower modeled downside.
SIGA
SIGA Technologies, Inc.
SIGA trails on the overall score without a compensating advantage in the available component scores.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
SIGA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Strong |
SIGA's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over SIGA in the historical PE scenario, which offers more potential upside but is not a forecast.
SIGA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $0.06 | -98% |
| Fair | 9.5x | $0.10 | -97% |
| Expensive | 16x | $0.16 | -94% |
| Current | 289x | $2.89 | — |
Historical ranges are pointers, not guarantees.
SIGA's PE is in its expensive range at 289x.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
SIGA Forward outlook
There aren't enough analyst estimates for SIGA to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over SIGA on earnings, with more consistent year-over-year improvement.
SIGA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.01 | -99% |
| Q2 2026 | -$0.04 | -104% |
| Q1 2026 | $0.28 | -58% |
| Q4 2025 | $0.32 | -61% |
| Q3 2025 | $1.02 | -15% |
| Q2 2025 | $1.13 | -3.4% |
| Q1 2025 | $0.67 | -39% |
| Q4 2024 | $0.82 | -14% |
SIGA's earnings per share have fallen from their peak: $0.01 over the past year, against $1.44 in late 2022.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over SIGA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over SIGA on profitability, with a higher operating margin.
SIGA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3M | -50% |
| Q2 2026 | $41M | -49% |
| Q1 2026 | $6.2M | -11% |
| Q4 2025 | $3.8M | -95% |
| Q3 2025 | $2.6M | -74% |
| Q2 2025 | $81.1M | +272% |
| Q1 2025 | $7M | -72% |
| Q4 2024 | $81.5M | -30% |
SIGA's revenue has slid since its 2023 peak: $1M last quarter, down 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -495% | -105 points |
| Q2 2026 | 34% | -22 points |
| Q1 2026 | -85% | -53 points |
| Q4 2025 | -250% | -320 points |
| Q3 2025 | -390% | -396 points |
| Q2 2025 | 56% | +51 points |
| Q1 2025 | -32% | -76 points |
| Q4 2024 | 70% | -8.6 points |
SIGA's operating margin was −495% last quarter, down 105 points from the same quarter a year ago, near the bottom of its range since 2019.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over SIGA on cash generation, producing positive trailing cash flow while its opponent burns cash.
SIGA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2M | +$8.9M |
| Q2 2026 | $15.2M | -76% |
| Q1 2026 | -$8.7M | -223% |
| Q4 2025 | -$16.9M | -130% |
| Q3 2025 | -$10.1M | -$2.7M |
| Q2 2025 | $63.1M | +960% |
| Q1 2025 | $7M | +$13.2M |
| Q4 2024 | $56.3M | -29% |
SIGA's free cash flow was −$12M over the past year, against $116M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SIGA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -34.7K shares |
| 1 year | +0.3% | +244K shares |
| 3 years | +1.1% | +764K shares |
| 5 years | -4% | -3M shares |
| Available history | -13% | -10.3M shares |
SIGA has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $3.5M |
| Q1 2023 | $7.6M |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
SIGA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -6.9x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -2.9x | Net Cash |
| Q4 2024 | -2.2x | Net Cash |
| Q3 2024 | -0.9x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
SIGA has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
SIGA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 21.2 | Neutral |
SIGA's weekly RSI is 33 (neutral) and its Stochastic is 21 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over SIGA on valuation relative to its sector.
SIGA PE vs Healthcare Sector
| Metric | SIGA | Sector median | Relative |
|---|---|---|---|
| PE | 289x | 26x | 1,018% above |
| PE % | 100 | 29 | 71 pts above |
SIGA is trading at 289x earnings, a 1018% premium to the Healthcare sector's median of 26x.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over SIGA on trend strength, trading above more of its moving averages.
SIGA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.18 | 9.1% below |
| 20 week MA | $3.22 | 10% below |
| 50 week MA | $4.58 | 37% below |
| 100 week MA | $5.66 | 49% below |
| 200 week MA | $6.08 | 52% below |
SIGA is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over SIGA on returns for 2026, with the stronger performance.
SIGA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.79 | $7.34 | +53% |
| 2021 | $7.34 | $7.99 | +8.9% |
| 2022 | $7.99 | $7.76 | -2.9% |
| 2023 | $7.76 | $5.60 | -28% |
| 2024 | $5.60 | $5.93 | +5.9% |
| 2025 | $5.93 | $6.27 | +5.7% |
| 2026 YTD | $6.27 | $2.89 | -54% |
SIGA is down 54% so far in 2026, after finishing higher in four of the previous six years.